124 related articles for article (PubMed ID: 9131155)
1. Epimer-specific actions of hepoxilins A3 and B3 on PAF- and bradykinin-evoked vascular permeability in the rat skin in vivo.
Wang MM; Demin PM; Pace-Asciak CR
Adv Exp Med Biol; 1996; 416():239-41. PubMed ID: 9131155
[No Abstract] [Full Text] [Related]
2. Stereoselective actions of hepoxilins A3 and B3 and their cyclopropane analogs (HxdeltaA3 and HxdeltaB3) on bradykinin and PAF-evoked potentiation of vascular leakage in rat skin.
Wang MM; Demin PM; Pace-Asciak CR
Gen Pharmacol; 1999 Nov; 33(5):377-82. PubMed ID: 10553878
[TBL] [Abstract][Full Text] [Related]
3. In vivo stimulation of 12(S)-lipoxygenase in the rat skin by bradykinin and platelet activating factor: formation of 12(S)-HETE and hepoxilins, and actions on vascular permeability.
Wang MM; Reynaud D; Pace-Asciak CR
Biochim Biophys Acta; 1999 Jan; 1436(3):354-62. PubMed ID: 9989266
[TBL] [Abstract][Full Text] [Related]
4. The mediators involved in endotoxin-induced vascular permeability increase in the rat skin and their interactions.
Ueno A; Tokumasu T; Naraba H; Oh-ishi S
Jpn J Pharmacol; 1996 Apr; 70(4):285-90. PubMed ID: 8774757
[TBL] [Abstract][Full Text] [Related]
5. Hepoxilin A3 increases vascular permeability in the rat skin.
Laneuville O; Corey EJ; Couture R; Pace-Asciak CR
Eicosanoids; 1991; 4(2):95-7. PubMed ID: 1910867
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory effects of platelet activating factor (PAF) in equine skin.
Foster AP; Cunningham FM; Lees P
Equine Vet J; 1992 May; 24(3):208-14. PubMed ID: 1606934
[TBL] [Abstract][Full Text] [Related]
7. Kinetics of endotoxin, complement and platelet-activating factor (PAF) induced vascular permeability in greyhounds.
Mills PC; Ng JC; Seawright AA; Auer DE
J Vet Pharmacol Ther; 1994 Dec; 17(6):470-2. PubMed ID: 7707493
[No Abstract] [Full Text] [Related]
8. Platelet activating factor (PAF) increases plasma protein extravasation and induces lowering of interstitial fluid pressure (P) in rat skin.
Iversen VV; Nedrebø T; Borge BA; Salvesen GS; Reed RK
Acta Physiol Scand; 2005 Sep; 185(1):5-12. PubMed ID: 16128692
[TBL] [Abstract][Full Text] [Related]
9. Involvement of bradykinin in endotoxin-induced vascular permeability increase in the skin of rats.
Ueno A; Tokumasu T; Naraba H; Oh-ishi S
Eur J Pharmacol; 1995 Sep; 284(1-2):211-4. PubMed ID: 8549629
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous and pulmonary histopathological responses to platelet activating factor (Paf-acether) in the guinea-pig.
Dewar A; Archer CB; Paul W; Page CP; MacDonald DM; Morley J
J Pathol; 1984 Sep; 144(1):25-34. PubMed ID: 6481526
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandins, kinin and inflammation in the rat.
Thomas G; West GB
Br J Pharmacol; 1974 Feb; 50(2):231-5. PubMed ID: 4154117
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the receptors mediating vascular actions of bradykinin.
Whalley ET; Nwator IA; Stewart JM; Vavrek RJ
Naunyn Schmiedebergs Arch Pharmacol; 1987 Oct; 336(4):430-3. PubMed ID: 2893297
[TBL] [Abstract][Full Text] [Related]
13. Platelet-activating factor increases vascular resistance in rat hindquarters by thromboxane A2.
Rizzo A; Taylor AE; Townsley MI; Logsdon P; Khimenko PL; Fletcher JR
Am J Physiol; 1995 May; 268(5 Pt 2):H1954-8. PubMed ID: 7771545
[TBL] [Abstract][Full Text] [Related]
14. Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist.
Hwang SB; Li CL; Lam MH; Shen TY
Lab Invest; 1985 Jun; 52(6):617-30. PubMed ID: 3925239
[TBL] [Abstract][Full Text] [Related]
15. Quantitative assessment of increased airway microvascular permeability to 125I-labelled plasma fibrinogen induced by platelet activating factor and bradykinin.
Pedersen KE; Rigby PJ; Goldie RG
Br J Pharmacol; 1991 Sep; 104(1):128-32. PubMed ID: 1664758
[TBL] [Abstract][Full Text] [Related]
16. Evidence that platelet activating factor may mediate some acute inflammatory responses. Studies with the platelet-activating factor antagonist, CV3988.
Issekutz AC; Szpejda M
Lab Invest; 1986 Mar; 54(3):275-81. PubMed ID: 3951199
[TBL] [Abstract][Full Text] [Related]
17. The effect of bradykinin on permeability of skin blood vessels.
Oyvin IA; Gaponiuk PY; Oyvin VI
Experientia; 1967 Nov; 23(11):925-6. PubMed ID: 6057009
[No Abstract] [Full Text] [Related]
18. Proceedings: Prostaglandin D1 inhibits the increase in vascular permeability in rat skin produced by prostaglandin E1, E2 and D2.
Flower RJ; Kingston WP
Br J Pharmacol; 1975 Oct; 55(2):239P-240P. PubMed ID: 1201383
[No Abstract] [Full Text] [Related]
19. Increase in vascular permeability produced in rat airways by PAF: potentiation by adrenalectomy.
Boschetto P; Musajo FG; Tognetto L; Boscaro M; Mapp CE; Barnes PJ; Fabbri LM
Br J Pharmacol; 1992 Feb; 105(2):388-92. PubMed ID: 1559129
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory oedema induced by synergism between calcitonin gene-related peptide (CGRP) and mediators of increased vascular permeability.
Brain SD; Williams TJ
Br J Pharmacol; 1985 Dec; 86(4):855-60. PubMed ID: 2416378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
